Irinotecan
- IVIrinotecanCamptosar
- Mechanism of Action
- Inhibits the activity of topoisomerase I, which is normally responsible for repairing DNA damage resulting from torsional strain.
Clinical Use
- Indication
- Certain solid organ organ malignancies, as guided by cancer specialists and local guidelines.
- Adverse Effects